Lang S M, Weeger M, Stahl-Hennig C, Coulibaly C, Hunsmann G, Müller J, Müller-Hermelink H, Fuchs D, Wachter H, Daniel M M
Institut für Klinische und Molekulare Virologie der Universität Erlangen-Nürnberg, Erlangen, Germany.
J Virol. 1993 Feb;67(2):902-12. doi: 10.1128/JVI.67.2.902-912.1993.
The importance of the vpr gene for simian immunodeficiency virus (SIV) replication, persistence, and disease progression was examined by using the infectious pathogenic molecular clone called SIVmac239. The ATG start codon of the vpr gene was converted to TTG by site-specific mutagenesis. The constructed Vpr- mutant virus is identical with the parental SIVmac239/nef-stop virus with the exception of this one nucleotide. These viruses replicated with similar kinetics and to similar extents in rhesus monkey lymphocyte cultures and in the human CEMX174 cell line. Five rhesus monkeys were inoculated with the Vpr- variant of SIVmac239/nef-stop, and two monkeys received SIVmac239/nef-stop as controls. Both controls showed reversion of the TAA stop signal in nef by 2 weeks postinfection, as has been observed previously. Reversion of the TAA stop codon in nef also occurred in the five monkeys that received the Vpr- variant, but reversion was delayed on average to about 4 weeks. Thus, the mutation in vpr appeared to delay the rapidity with which reversion occurred in the nef gene. Reversion of the TTG sequence in vpr to ATG was observed in three of the five test animals. Reversion in vpr was first observed in these three animals 4 to 8 weeks postinfection. No vpr revertants were found over the entire 66 weeks of observation in the other two test animals that received the vpr mutant. Antibodies to vpr developed in those three animals in which reversion of vpr was documented, but antibodies to vpr were not observed in the two animals in which reversion of vpr was not detected. Antibody responses to gag and to whole virus antigens were of similar strength in all seven animals. Both control animals and two of the test animals in which vpr reverted maintained high virus loads and developed progressive disease. Low virus burden and no disease have been observed in the two animals in which vpr did not revert and in the one animal in which vpr reversion was first detected only at 8 weeks. The reversion of vpr in three of the five test animals indicates that there is significant selective pressure for functional forms of vpr in vivo. Furthermore, the results suggest that both vpr and nef are important for maximal SIV replication and persistence in vivo and for disease progression.
利用名为SIVmac239的感染性致病分子克隆,研究了vpr基因对猴免疫缺陷病毒(SIV)复制、持续存在及疾病进展的重要性。通过位点特异性诱变将vpr基因的ATG起始密码子转换为TTG。构建的Vpr-突变病毒除了这一个核苷酸外,与亲本SIVmac239/nef-stop病毒相同。这些病毒在恒河猴淋巴细胞培养物和人CEMX174细胞系中以相似的动力学和相似的程度进行复制。给5只恒河猴接种SIVmac239/nef-stop的Vpr-变体,2只猴子接种SIVmac239/nef-stop作为对照。如先前观察到的那样,两个对照组在感染后2周时nef中的TAA终止信号均发生了回复突变。接受Vpr-变体的5只猴子中nef的TAA终止密码子也发生了回复突变,但平均延迟到约4周。因此,vpr中的突变似乎延迟了nef基因中回复突变发生的速度。在5只受试动物中的3只中观察到vpr中的TTG序列回复为ATG。在这3只动物中,感染后4至8周首次观察到vpr的回复突变。在接受vpr突变体的另外2只受试动物的整个66周观察期内未发现vpr回复体。在记录到vpr回复突变的3只动物中产生了针对vpr的抗体,但在未检测到vpr回复突变的2只动物中未观察到针对vpr的抗体。在所有7只动物中,对gag和全病毒抗原的抗体反应强度相似。两只对照动物以及vpr发生回复突变的2只受试动物均维持高病毒载量并发展为进行性疾病。在vpr未发生回复突变的2只动物以及仅在第8周才首次检测到vpr回复突变的1只动物中,观察到低病毒载量且无疾病发生。5只受试动物中的3只出现vpr回复突变,这表明体内对功能性vpr形式存在显著的选择压力。此外,结果表明vpr和nef对于SIV在体内的最大复制、持续存在以及疾病进展均很重要。